Britain’s summer of discontent: when borders, bills and billionaires rewrite the rules

Britain is melting. Not just under the summer sun, but under the weight of decisions made in its name—yet without its consent. This week, three stories have collided to expose the fault lines of a country still grappling with its post-Brexit identity, its economic sovereignty, and the quiet war over who gets to shape its future. The EU’s new border checks are turning holidays into endurance tests. A £35bn nuclear bet by a Polish billionaire promises to power datacentres but leaves questions about who really benefits. And a US pharma deal, rammed through parliament in the dying days of the Starmer government, threatens to bleed the NHS dry. Together, they paint a picture of a nation caught between the grind of daily survival and the high-stakes gambles of its elites.

The EU border: when security becomes a holiday tax

The digital entry and exit system (EES) was supposed to be a seamless upgrade to Europe’s borders. Instead, it’s become a summer nightmare. Since October, non-EU travellers—including Brits—have been forced to register fingerprints and facial scans at EU borders, turning what should be a quick passport check into a five-hour ordeal. Airlines and airports are now begging for the system to be suspended during peak season, warning that flights are taking off half-empty as passengers miss connections. The irony? This is the kind of friction Brexit was supposed to avoid. Instead, it’s a reminder that leaving the EU didn’t mean escaping its rules—just its protections.

The delays aren’t just inconvenient; they’re a tax on mobility. For families already stretched by the cost of living, a missed flight or an extra night in a hotel can mean the difference between a holiday and a financial headache. And for the UK’s struggling tourism sector, the message is clear: Europe is still open for business, but the welcome mat is fraying. The government’s response? Silence. No pressure on Brussels, no diplomatic push to ease the burden. Just another example of Britain’s post-Brexit strategy: hope for the best and ignore the rest.

The £35bn nuclear gamble: who’s really powering Britain’s future?

Michał Sołowow, the Polish billionaire behind a £35bn plan to build 14 small modular reactors (SMRs) across the UK, isn’t just selling energy—he’s selling a vision. Enough power for 8 million homes, a lifeline for datacentres hungry for clean energy, and a private-sector solution to Britain’s energy crisis. But scratch beneath the surface, and the questions multiply. Why is a Polish industrialist—with no prior nuclear experience—suddenly the saviour of Britain’s grid? And why are these reactors being pitched as a solution for datacentres, not for the households still struggling with energy bills?

The timing is telling. With Labour’s Andy Burnham under pressure to adopt a more radical economic agenda, this deal smells like a pre-emptive strike by the private sector. If the state won’t step in, billionaires will—on their terms. And those terms? A 60-year commitment to a technology that’s still unproven at scale, with profits likely flowing back to shareholders rather than into public coffers. The government, desperate for investment, is waving it through. But for how long will voters tolerate a system where the rich get to rewrite the rules of energy—while the rest of us foot the bill?

The US pharma deal: when healthcare becomes a corporate ATM

Keir Starmer’s government may be gone, but its parting gift to Britain is a US pharma deal that could prove more lethal than Covid. The treaty, rushed through parliament in its final days, will allow American drug companies to charge the NHS higher prices for medicines—prices that independent experts warn could cost billions. The money won’t go to doctors, nurses, or cancer scans. It will go to shareholders in New York and Boston.

This isn’t just bad policy; it’s a democratic failure. The government didn’t even come clean about the costs. No impact assessment, no public debate. Just a quiet nod to corporate interests, dressed up as a necessary evil. The message to the British public? Your healthcare isn’t a right—it’s a market. And in that market, the house always wins.

The quiet rebellion: Burnham’s populist gamble

As these battles rage, Andy Burnham is being urged to go further. A new poll, circulated among his advisers, suggests Labour’s majority could collapse at the next election unless it adopts a more radical economic agenda. Rent controls, wealth taxes, a crackdown on corporate profiteering—these aren’t just policies; they’re a survival strategy. The question is whether Burnham has the stomach for the fight.

The cost of living squeeze may be easing—diesel prices are down, mortgage rates are dropping—but the underlying fractures remain. Wages are stagnant. Rents are soaring. And the public is tired of being told that the only way forward is to tighten their belts while the rich get richer. Burnham’s challenge isn’t just economic; it’s cultural. Can he convince Britain that the system isn’t broken—it’s rigged? And if he can, will he have the courage to unrig it?

What it all means: Britain’s summer of reckoning

This summer isn’t just about heatwaves and holidays. It’s about who gets to shape Britain’s future—and on whose terms. The EU border chaos is a reminder that Brexit didn’t free Britain from Europe’s rules; it just left it at their mercy. The nuclear deal is a warning that if the state won’t step in, billionaires will—with their own agendas. And the pharma treaty is a betrayal of the idea that public services exist to serve the public, not corporate interests.

The question now is whether Britain’s leaders are willing to fight back—or whether they’ll keep pretending that the system works, even as it fails the people it’s meant to serve. One thing is clear: the summer of discontent is only just beginning.